Status:
UNKNOWN
PLIN1 Variants in Precocious ACS (SCAPLIN)
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
10-55 years
Phase:
NA
Brief Summary
This study aims to identify a genetic predisposition factor of precocious acute coronary syndrome occurrence (ACS). ACS is a major public health problem and the first cause of mortality in the world. ...
Eligibility Criteria
Inclusion
- Age of the patient when ACS occurs (between 18 and 50yo for men, between 18 and 55yo for women)
- Written informed consent
Exclusion
- Men \<18yo or \>50yo
- Women \<18yo or \>55yo
- ACS causes (toxic, coronary dissection)
- Congenital cardiac malformations
- Familial hypercholesterolaemia
- Pregnancy, breast-feeding women or vulnerable profile.
- Patient refusal to participate or previously included in a clinical research trial.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04904432
Start Date
September 15 2021
End Date
June 1 2024
Last Update
October 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13005